Status:
COMPLETED
Low Plasma Mannose Binding Lectin (p-MBL) Level is a Risk Factor for Recurrent Pregnancy Loss (RPL)
Lead Sponsor:
Aalborg University Hospital
Conditions:
Recurrent Miscarriage
Spontaneous Abortion
Eligibility:
FEMALE
18-45 years
Brief Summary
The present study is based on the hypothesis, that recurrent pregnancy loss (RPL) is associated with abnormal plasma mannose binding lectin (p-MBL) level. Secondarily, p-MBL level may affect the repro...
Detailed Description
Recurrent pregnancy loss (RPL), defined as 3 or more consecutive pregnancy losses before 22 weeks of gestation, is a multifactorial disorder affecting 1-3% of all females of reproductive age. The unde...
Eligibility Criteria
Inclusion
- \- Women admitted to the Centre for Recurrent Pregnancy Loss of Western Denmark January 2016 to March 2020
Exclusion
- Less than 3 consecutive pregnancy losses
- Significant uterine malformation on hydrosonography or hysteroscopy
- Significant chromosomal abnormalities
- Abnormal menstrual cycle length (\<22 or \>35 days) or irregular cycle
- Pregnancy at first meeting in the Recurrent Miscarriage Clinic
- Age \<18 and \>45 years
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 29 2021
Estimated Enrollment :
452 Patients enrolled
Trial Details
Trial ID
NCT04017754
Start Date
January 1 2016
End Date
March 29 2021
Last Update
July 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aalborg University Hospital
Aalborg, Denmark, 9000